Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

127
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
127
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing geriatric assessment tools for predicting negative health outcomes in older adults.

BMC medicine·2026
Same author

Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology.

JAMA network open·2026
Same author

Association between atrial fibrillation and systemic inflammation with muscle mass and strength trajectories in old age.

GeroScience·2026
Same author

Cardiology care, cardiovascular comorbidities and all-cause mortality in long-term breast cancer survivors: a retrospective cohort study.

Revista espanola de cardiologia (English ed.)·2026
Same author

Feasibility and acceptability of the Health Assessment Tool (HAT) in Swedish primary care: insights into older patients' needs and professional perspectives.

Scandinavian journal of primary health care·2026
Same author

Social frailty as a predictor of mortality among older adults in four Colombian departments: evidence from the SABE survey.

BMC geriatrics·2026

Related Experiment Video

Updated: May 4, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Polypharmacy patterns: unravelling systematic associations between prescribed medications.

Amaia Calderón-Larrañaga1, Luis A Gimeno-Feliu2, Francisca González-Rubio3

  • 1EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain ; Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain ; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Carlos III Health Institute, Madrid, Spain ; Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute (IACS), IIS Aragón, Zaragoza, Spain.

Plos One
|December 31, 2013
PubMed
Summary

This study identified seven non-random drug prescription patterns, revealing consistent polypharmacy in adult patients. These findings support clinical guidelines for managing multiple medications in complex conditions.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: May 4, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.0K

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Polypharmacy, the concurrent use of multiple medications, is common in adult patients.
  • Understanding drug prescription patterns is crucial for optimizing patient care and safety.

Purpose of the Study:

  • To identify systematic associations in drug prescription leading to polypharmacy patterns.
  • To interpret the clinical significance of identified polypharmacy patterns.

Main Methods:

  • A cross-sectional study analyzed drug dispensing data from 79,089 adult patients.
  • Exploratory factor analysis identified polypharmacy patterns, stratified by age and sex.

Main Results:

  • Seven distinct polypharmacy patterns were identified, categorized by disease indication (e.g., cardiovascular, respiratory, pain).
  • Patterns showed clinical consistency, with drugs prescribed for related conditions or to manage side effects.
  • Complex patterns integrated treatments for risk factors, comorbidities, and established pathologies.

Conclusions:

  • Non-random drug prescription patterns resulting in clinically sound polypharmacy exist in a significant patient population.
  • Further longitudinal studies are needed to confirm causal associations.
  • Findings can inform clinical guidelines for patients with multimorbidity and polypharmacy.